APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Aurora Kinase A

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Aurora Kinase A Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173968290319 December 2025194 pages

Choose your research edition.

Industry ResearchAurora Kinase A Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Aurora Kinase A Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Aurora Kinase A Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aurora Kinase A Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Aurora Kinase A Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Aurora Kinase A market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Aurora Kinase A is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Aurora Kinase A is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Aurora Kinase A is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Aurora Kinase A is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Aurora Kinase A include Sanofi, Merck & Co., Inc., Amgen Inc., AbbVie Inc., Vichem Chemie Research Ltd., Vertex Pharmaceuticals Incorporated, Taiho Pharmaceutical Co., Ltd., Sigma-Tau S.p.A. and Sareum Holdings Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Aurora Kinase A market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Aurora Kinase A and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Aurora Kinase A sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Aurora Kinase A market size, projected growth trends, production technologies, key applications, and end-use industries.

Aurora Kinase A Segment by Company

Sanofi

Merck & Co., Inc.

Amgen Inc.

AbbVie Inc.

Vichem Chemie Research Ltd.

Vertex Pharmaceuticals Incorporated

Taiho Pharmaceutical Co., Ltd.

Sigma-Tau S.p.A.

Sareum Holdings Plc

Millennium Pharmaceuticals, Inc.

CASI Pharmaceuticals Inc.

Astex Pharmaceuticals, Inc.

Aurora Kinase A Segment by Type

AMG-900

Ilorasertib

ENMD-2076

Danusertib

Others

Aurora Kinase A Segment by Application

Brain Tumor

Ovarian Cancer

Anaplastic Large Cell Lymphoma

Others

Aurora Kinase A Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aurora Kinase A market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aurora Kinase A and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aurora Kinase A.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Aurora Kinase A market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Aurora Kinase A manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Aurora Kinase A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Aurora Kinase A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Aurora Kinase A Industry Trends Table 2. Aurora Kinase A Industry Drivers Table 3. Aurora Kinase A Industry Opportunities and Challenges Table 4. Aurora Kinase A Industry Restraints Table 5. Global Aurora Kinase A Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Aurora Kinase A Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Aurora Kinase A Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Aurora Kinase A Sales Market Share by Manufacturers Table 9. Global Aurora Kinase A Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Aurora Kinase A Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Aurora Kinase A Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Aurora Kinase A Manufacturers, Product Type & Application Table 13. Global Aurora Kinase A Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Aurora Kinase A by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of AMG-900 Table 17. Major Manufacturers of Ilorasertib Table 18. Major Manufacturers of ENMD-2076 Table 19. Major Manufacturers of Danusertib Table 20. Major Manufacturers of Others Table 21. Global Aurora Kinase A Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Aurora Kinase A Sales by Type (2021-2026) & (K Units) Table 23. Global Aurora Kinase A Sales by Type (2027-2032) & (K Units) Table 24. Global Aurora Kinase A Sales Market Share by Type (2021-2026) Table 25. Global Aurora Kinase A Sales Market Share by Type (2027-2032) Table 26. Global Aurora Kinase A Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Aurora Kinase A Revenue by Type (2021-2026) & (K Units) Table 28. Global Aurora Kinase A Revenue by Type (2027-2032) & (K Units) Table 29. Global Aurora Kinase A Revenue Market Share by Type (2021-2026) Table 30. Global Aurora Kinase A Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Brain Tumor Table 32. Major Manufacturers of Ovarian Cancer Table 33. Major Manufacturers of Anaplastic Large Cell Lymphoma Table 34. Major Manufacturers of Others Table 35. Global Aurora Kinase A Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Aurora Kinase A Sales by Application (2021-2026) & (K Units) Table 37. Global Aurora Kinase A Sales by Application (2027-2032) & (K Units) Table 38. Global Aurora Kinase A Sales Market Share by Application (2021-2026) Table 39. Global Aurora Kinase A Sales Market Share by Application (2027-2032) Table 40. Global Aurora Kinase A Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Aurora Kinase A Revenue by Application (2021-2026) & (K Units) Table 42. Global Aurora Kinase A Revenue by Application (2027-2032) & (K Units) Table 43. Global Aurora Kinase A Revenue Market Share by Application (2021-2026) Table 44. Global Aurora Kinase A Revenue Market Share by Application (2027-2032) Table 45. Global Aurora Kinase A Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Aurora Kinase A Sales by Region (2021-2026) & (K Units) Table 47. Global Aurora Kinase A Sales Market Share by Region (2021-2026) Table 48. Global Aurora Kinase A Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global Aurora Kinase A Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Aurora Kinase A Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America Aurora Kinase A Sales by Country (2021-2026) & (K Units) Table 52. North America Aurora Kinase A Sales by Country (2027-2032) & (K Units) Table 53. Europe Aurora Kinase A Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe Aurora Kinase A Sales by Country (2021-2026) & (K Units) Table 55. Europe Aurora Kinase A Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific Aurora Kinase A Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific Aurora Kinase A Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific Aurora Kinase A Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa Aurora Kinase A Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa Aurora Kinase A Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa Aurora Kinase A Sales by Country (2027-2032) & (K Units) Table 62. Global Aurora Kinase A Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Aurora Kinase A Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Aurora Kinase A Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Aurora Kinase A Revenue Market Share by Region (2021-2026) Table 66. Global Aurora Kinase A Revenue Market Share by Region (2027-2032) Table 67. Sanofi Company Information Table 68. Sanofi Business Overview Table 69. Sanofi Aurora Kinase A Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Sanofi Aurora Kinase A Product Portfolio Table 71. Sanofi Recent Development Table 72. Merck & Co., Inc. Company Information Table 73. Merck & Co., Inc. Business Overview Table 74. Merck & Co., Inc. Aurora Kinase A Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Merck & Co., Inc. Aurora Kinase A Product Portfolio Table 76. Merck & Co., Inc. Recent Development Table 77. Amgen Inc. Company Information Table 78. Amgen Inc. Business Overview Table 79. Amgen Inc. Aurora Kinase A Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Amgen Inc. Aurora Kinase A Product Portfolio Table 81. Amgen Inc. Recent Development Table 82. AbbVie Inc. Company Information Table 83. AbbVie Inc. Business Overview Table 84. AbbVie Inc. Aurora Kinase A Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. AbbVie Inc. Aurora Kinase A Product Portfolio Table 86. AbbVie Inc. Recent Development Table 87. Vichem Chemie Research Ltd. Company Information Table 88. Vichem Chemie Research Ltd. Business Overview Table 89. Vichem Chemie Research Ltd. Aurora Kinase A Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Vichem Chemie Research Ltd. Aurora Kinase A Product Portfolio Table 91. Vichem Chemie Research Ltd. Recent Development Table 92. Vertex Pharmaceuticals Incorporated Company Information Table 93. Vertex Pharmaceuticals Incorporated Business Overview Table 94. Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Vertex Pharmaceuticals Incorporated Aurora Kinase A Product Portfolio Table 96. Vertex Pharmaceuticals Incorporated Recent Development Table 97. Taiho Pharmaceutical Co., Ltd. Company Information Table 98. Taiho Pharmaceutical Co., Ltd. Business Overview Table 99. Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product Portfolio Table 101. Taiho Pharmaceutical Co., Ltd. Recent Development Table 102. Sigma-Tau S.p.A. Company Information Table 103. Sigma-Tau S.p.A. Business Overview Table 104. Sigma-Tau S.p.A. Aurora Kinase A Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Sigma-Tau S.p.A. Aurora Kinase A Product Portfolio Table 106. Sigma-Tau S.p.A. Recent Development Table 107. Sareum Holdings Plc Company Information Table 108. Sareum Holdings Plc Business Overview Table 109. Sareum Holdings Plc Aurora Kinase A Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Sareum Holdings Plc Aurora Kinase A Product Portfolio Table 111. Sareum Holdings Plc Recent Development Table 112. Millennium Pharmaceuticals, Inc. Company Information Table 113. Millennium Pharmaceuticals, Inc. Business Overview Table 114. Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Millennium Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio Table 116. Millennium Pharmaceuticals, Inc. Recent Development Table 117. CASI Pharmaceuticals Inc. Company Information Table 118. CASI Pharmaceuticals Inc. Business Overview Table 119. CASI Pharmaceuticals Inc. Aurora Kinase A Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. CASI Pharmaceuticals Inc. Aurora Kinase A Product Portfolio Table 121. CASI Pharmaceuticals Inc. Recent Development Table 122. Astex Pharmaceuticals, Inc. Company Information Table 123. Astex Pharmaceuticals, Inc. Business Overview Table 124. Astex Pharmaceuticals, Inc. Aurora Kinase A Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Astex Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio Table 126. Astex Pharmaceuticals, Inc. Recent Development Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Aurora Kinase A Distributors List Table 130. Aurora Kinase A Customers List Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Aurora Kinase A Product Image Figure 2. Global Aurora Kinase A Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aurora Kinase A Market Size (2021-2032) & (US$ Million) Figure 4. Global Aurora Kinase A Sales (2021-2032) & (K Units) Figure 5. Global Aurora Kinase A Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Aurora Kinase A Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. AMG-900 Image Figure 9. Ilorasertib Image Figure 10. ENMD-2076 Image Figure 11. Danusertib Image Figure 12. Others Image Figure 13. Global Aurora Kinase A Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Aurora Kinase A Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Aurora Kinase A Sales Market Share by Type (2021-2032) Figure 16. Global Aurora Kinase A Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Aurora Kinase A Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Aurora Kinase A Revenue Market Share by Type (2021-2032) Figure 19. Brain Tumor Image Figure 20. Ovarian Cancer Image Figure 21. Anaplastic Large Cell Lymphoma Image Figure 22. Others Image Figure 23. Global Aurora Kinase A Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Aurora Kinase A Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Aurora Kinase A Sales Market Share by Application (2021-2032) Figure 26. Global Aurora Kinase A Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Aurora Kinase A Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Aurora Kinase A Revenue Market Share by Application (2021-2032) Figure 29. North America Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America Aurora Kinase A Sales Market Share by Country (2021-2032) Figure 31. U.S. Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Aurora Kinase A Sales Market Share by Country (2021-2032) Figure 36. Germany Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Aurora Kinase A Sales Market Share by Country (2021-2032) Figure 43. China Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Aurora Kinase A Sales Market Share by Country (2021-2032) Figure 51. Brazil Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile Aurora Kinase A Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global Aurora Kinase A Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Aurora Kinase A Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Aurora Kinase A Revenue (2021-2032) & (US$ Million) Figure 62. North America Aurora Kinase A Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Aurora Kinase A Revenue (2021-2032) & (US$ Million) Figure 64. Europe Aurora Kinase A Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Aurora Kinase A Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Aurora Kinase A Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Aurora Kinase A Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Aurora Kinase A Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Aurora Kinase A Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Aurora Kinase A Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • AMG-900
  • Ilorasertib
  • ENMD-2076
  • Danusertib
  • Others
Applications
  • Brain Tumor
  • Ovarian Cancer
  • Anaplastic Large Cell Lymphoma
  • Others
Companies covered
  • Sanofi
  • Merck & Co., Inc.
  • Amgen Inc.
  • AbbVie Inc.
  • Vichem Chemie Research Ltd.
  • Vertex Pharmaceuticals Incorporated
  • Taiho Pharmaceutical Co., Ltd.
  • Sigma-Tau S.p.A.
  • Sareum Holdings Plc
  • Millennium Pharmaceuticals, Inc.
  • CASI Pharmaceuticals Inc.
  • Astex Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Aurora Kinase A Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Aurora Kinase A Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Aurora Kinase A Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Aurora Kinase A Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Aurora Kinase A Market Dynamics
  1. 2.1 Aurora Kinase A Industry Trends
  2. 2.2 Aurora Kinase A Industry Drivers
  3. 2.3 Aurora Kinase A Industry Opportunities and Challenges
  4. 2.4 Aurora Kinase A Industry Restraints
3 Aurora Kinase A Market by Manufacturers
  1. 3.1 Global Aurora Kinase A Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Aurora Kinase A Sales by Manufacturers (2021-2026)
  3. 3.3 Global Aurora Kinase A Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Aurora Kinase A Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Aurora Kinase A Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Aurora Kinase A Manufacturers, Product Type & Application
  7. 3.7 Global Aurora Kinase A Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Aurora Kinase A Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Aurora Kinase A Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Aurora Kinase A Tier 1, Tier 2, and Tier 3
4 Aurora Kinase A Market by Type
  1. 4.1 Aurora Kinase A Type Introduction
  2. 4.1.1 AMG-900
  3. 4.1.2 Ilorasertib
  4. 4.1.3 ENMD-2076
  5. 4.1.4 Danusertib
  6. 4.1.5 Others
  7. 4.2 Global Aurora Kinase A Sales by Type
  8. 4.2.1 Global Aurora Kinase A Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Aurora Kinase A Sales by Type (2021-2032)
  10. 4.2.3 Global Aurora Kinase A Sales Market Share by Type (2021-2032)
  11. 4.3 Global Aurora Kinase A Revenue by Type
  12. 4.3.1 Global Aurora Kinase A Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Aurora Kinase A Revenue by Type (2021-2032)
  14. 4.3.3 Global Aurora Kinase A Revenue Market Share by Type (2021-2032)
5 Aurora Kinase A Market by Application
  1. 5.1 Aurora Kinase A Application Introduction
  2. 5.1.1 Brain Tumor
  3. 5.1.2 Ovarian Cancer
  4. 5.1.3 Anaplastic Large Cell Lymphoma
  5. 5.1.4 Others
  6. 5.2 Global Aurora Kinase A Sales by Application
  7. 5.2.1 Global Aurora Kinase A Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Aurora Kinase A Sales by Application (2021-2032)
  9. 5.2.3 Global Aurora Kinase A Sales Market Share by Application (2021-2032)
  10. 5.3 Global Aurora Kinase A Revenue by Application
  11. 5.3.1 Global Aurora Kinase A Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Aurora Kinase A Revenue by Application (2021-2032)
  13. 5.3.3 Global Aurora Kinase A Revenue Market Share by Application (2021-2032)
6 Global Aurora Kinase A Sales by Region
  1. 6.1 Global Aurora Kinase A Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Aurora Kinase A Sales by Region (2021-2032)
  3. 6.2.1 Global Aurora Kinase A Sales by Region (2021-2026)
  4. 6.2.2 Global Aurora Kinase A Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Aurora Kinase A Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Aurora Kinase A Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Aurora Kinase A Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Aurora Kinase A Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Aurora Kinase A Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Aurora Kinase A Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Aurora Kinase A Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Aurora Kinase A Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Aurora Kinase A Revenue by Region
  1. 7.1 Global Aurora Kinase A Revenue by Region
  2. 7.1.1 Global Aurora Kinase A Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Aurora Kinase A Revenue by Region (2021-2026)
  4. 7.1.3 Global Aurora Kinase A Revenue by Region (2027-2032)
  5. 7.1.4 Global Aurora Kinase A Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Aurora Kinase A Revenue (2021-2032)
  8. 7.2.2 North America Aurora Kinase A Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Aurora Kinase A Revenue (2021-2032)
  11. 7.3.2 Europe Aurora Kinase A Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Aurora Kinase A Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Aurora Kinase A Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Aurora Kinase A Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Aurora Kinase A Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Aurora Kinase A Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Aurora Kinase A Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Merck & Co., Inc.
  8. 8.2.1 Merck & Co., Inc. Company Information
  9. 8.2.2 Merck & Co., Inc. Business Overview
  10. 8.2.3 Merck & Co., Inc. Aurora Kinase A Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co., Inc. Aurora Kinase A Product Portfolio
  12. 8.2.5 Merck & Co., Inc. Recent Developments
  13. 8.3 Amgen Inc.
  14. 8.3.1 Amgen Inc. Company Information
  15. 8.3.2 Amgen Inc. Business Overview
  16. 8.3.3 Amgen Inc. Aurora Kinase A Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Amgen Inc. Aurora Kinase A Product Portfolio
  18. 8.3.5 Amgen Inc. Recent Developments
  19. 8.4 AbbVie Inc.
  20. 8.4.1 AbbVie Inc. Company Information
  21. 8.4.2 AbbVie Inc. Business Overview
  22. 8.4.3 AbbVie Inc. Aurora Kinase A Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AbbVie Inc. Aurora Kinase A Product Portfolio
  24. 8.4.5 AbbVie Inc. Recent Developments
  25. 8.5 Vichem Chemie Research Ltd.
  26. 8.5.1 Vichem Chemie Research Ltd. Company Information
  27. 8.5.2 Vichem Chemie Research Ltd. Business Overview
  28. 8.5.3 Vichem Chemie Research Ltd. Aurora Kinase A Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vichem Chemie Research Ltd. Aurora Kinase A Product Portfolio
  30. 8.5.5 Vichem Chemie Research Ltd. Recent Developments
  31. 8.6 Vertex Pharmaceuticals Incorporated
  32. 8.6.1 Vertex Pharmaceuticals Incorporated Company Information
  33. 8.6.2 Vertex Pharmaceuticals Incorporated Business Overview
  34. 8.6.3 Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Vertex Pharmaceuticals Incorporated Aurora Kinase A Product Portfolio
  36. 8.6.5 Vertex Pharmaceuticals Incorporated Recent Developments
  37. 8.7 Taiho Pharmaceutical Co., Ltd.
  38. 8.7.1 Taiho Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Taiho Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product Portfolio
  42. 8.7.5 Taiho Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Sigma-Tau S.p.A.
  44. 8.8.1 Sigma-Tau S.p.A. Company Information
  45. 8.8.2 Sigma-Tau S.p.A. Business Overview
  46. 8.8.3 Sigma-Tau S.p.A. Aurora Kinase A Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sigma-Tau S.p.A. Aurora Kinase A Product Portfolio
  48. 8.8.5 Sigma-Tau S.p.A. Recent Developments
  49. 8.9 Sareum Holdings Plc
  50. 8.9.1 Sareum Holdings Plc Company Information
  51. 8.9.2 Sareum Holdings Plc Business Overview
  52. 8.9.3 Sareum Holdings Plc Aurora Kinase A Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sareum Holdings Plc Aurora Kinase A Product Portfolio
  54. 8.9.5 Sareum Holdings Plc Recent Developments
  55. 8.10 Millennium Pharmaceuticals, Inc.
  56. 8.10.1 Millennium Pharmaceuticals, Inc. Company Information
  57. 8.10.2 Millennium Pharmaceuticals, Inc. Business Overview
  58. 8.10.3 Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Millennium Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio
  60. 8.10.5 Millennium Pharmaceuticals, Inc. Recent Developments
  61. 8.11 CASI Pharmaceuticals Inc.
  62. 8.11.1 CASI Pharmaceuticals Inc. Company Information
  63. 8.11.2 CASI Pharmaceuticals Inc. Business Overview
  64. 8.11.3 CASI Pharmaceuticals Inc. Aurora Kinase A Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CASI Pharmaceuticals Inc. Aurora Kinase A Product Portfolio
  66. 8.11.5 CASI Pharmaceuticals Inc. Recent Developments
  67. 8.12 Astex Pharmaceuticals, Inc.
  68. 8.12.1 Astex Pharmaceuticals, Inc. Company Information
  69. 8.12.2 Astex Pharmaceuticals, Inc. Business Overview
  70. 8.12.3 Astex Pharmaceuticals, Inc. Aurora Kinase A Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Astex Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio
  72. 8.12.5 Astex Pharmaceuticals, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Aurora Kinase A Value Chain Analysis
  2. 9.1.1 Aurora Kinase A Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Aurora Kinase A Production Mode & Process
  6. 9.2 Aurora Kinase A Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Aurora Kinase A Distributors
  9. 9.2.3 Aurora Kinase A Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst